Technical Trend Overview and Moving Averages
Kopran’s technical trend has deteriorated from mildly bearish to outright bearish, signalling a shift in market sentiment. The daily moving averages reinforce this negative outlook, with the stock trading below key averages, indicating sustained downward momentum. The 50-day and 200-day moving averages have yet to show signs of convergence or bullish crossover, which would be necessary to suggest a reversal in trend.
The daily moving averages’ bearish stance is consistent with the stock’s recent price action, where the intraday low touched ₹133.30 and the high was capped at ₹141.75, well below the 52-week high of ₹216.25. This price compression near the lower end of the range highlights the pressure on the stock and the lack of strong buying interest at higher levels.
MACD and RSI Signals
The Moving Average Convergence Divergence (MACD) indicator presents a mixed picture. On a weekly basis, the MACD remains mildly bullish, suggesting some underlying positive momentum in the short term. However, the monthly MACD is bearish, indicating that the longer-term trend remains negative. This divergence between weekly and monthly MACD readings suggests that while short-term traders might find some opportunities, the broader trend is still unfavourable.
Relative Strength Index (RSI) readings on both weekly and monthly charts currently show no clear signal, hovering in neutral zones. This lack of momentum in the RSI implies that the stock is neither overbought nor oversold, which could mean that the current downtrend has room to continue before a significant reversal occurs.
Bollinger Bands and KST Analysis
Bollinger Bands on both weekly and monthly timeframes are signalling bearish conditions. The stock price is near the lower band, indicating increased volatility and downward pressure. This technical setup often precedes further declines unless a strong catalyst emerges to push prices back towards the mean.
The Know Sure Thing (KST) indicator, a momentum oscillator, confirms the bearish outlook on both weekly and monthly charts. The KST’s downward trajectory aligns with the broader technical deterioration, reinforcing the cautionary stance for investors.
On-Balance Volume and Dow Theory
Interestingly, the On-Balance Volume (OBV) indicator is bullish on both weekly and monthly charts. This suggests that despite price declines, there is accumulation happening behind the scenes, possibly by institutional investors or long-term holders. This divergence between price and volume could signal a potential base formation, but it remains premature to call a definitive trend reversal.
Dow Theory assessments show a mildly bearish trend on the weekly timeframe, while the monthly trend is classified as having no clear direction. This mixed signal further emphasises the uncertainty in the stock’s medium-term outlook.
Price Performance Relative to Sensex
Over the past week, Kopran’s stock has underperformed the Sensex, declining by 6.51% compared to the benchmark’s 1.73% fall. However, over the last month, Kopran has outperformed with a 6.07% gain while the Sensex dropped 3.24%. Year-to-date, the stock remains down 7.97%, underperforming the Sensex’s 3.57% decline.
Longer-term returns paint a more challenging picture for Kopran. Over the past year, the stock has fallen 33.88%, while the Sensex gained 6.63%. Over three and five years, Kopran’s returns are modest at 0.29% and 7.02% respectively, lagging significantly behind the Sensex’s 35.56% and 65.05% gains. Even over a decade, Kopran’s 158.82% return trails the Sensex’s 241.54%, highlighting persistent underperformance relative to the broader market.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
See What's Driving the Rally →
Mojo Score and Analyst Ratings
Kopran’s current Mojo Score stands at 26.0, reflecting a strong sell recommendation. This is a downgrade from the previous Sell grade, effective from 20 Jan 2026. The downgrade reflects deteriorating fundamentals and technicals, signalling increased risk for investors. The Market Cap Grade is a low 4, indicating limited market capitalisation strength relative to peers.
Such a low Mojo Grade suggests that investors should exercise caution and consider reducing exposure or avoiding new positions until technical and fundamental conditions improve.
Sector Context and Industry Comparison
Within the Pharmaceuticals & Biotechnology sector, Kopran’s technical deterioration contrasts with some peers that have shown resilience or modest recovery. The sector overall has been volatile, influenced by regulatory developments, R&D pipeline progress, and broader market rotations into defensive stocks.
Investors should weigh Kopran’s technical weakness against sector trends and consider alternative stocks with stronger momentum and fundamentals.
Holding Kopran Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investor Takeaway and Outlook
Technical indicators for Kopran Ltd currently signal a bearish momentum with limited short-term relief. The daily moving averages and monthly MACD confirm downward pressure, while the weekly MACD and OBV provide some cautious optimism for potential accumulation. However, the absence of strong RSI signals and the bearish KST and Bollinger Bands suggest that the stock may continue to face selling pressure in the near term.
Given the stock’s underperformance relative to the Sensex over multiple time horizons and the recent downgrade to a Strong Sell grade, investors should approach Kopran with caution. Those holding the stock may consider trimming positions or monitoring for a confirmed technical reversal before adding exposure. Prospective buyers should await clearer signs of momentum improvement and fundamental catalysts.
In the broader Pharmaceuticals & Biotechnology sector, selective opportunities exist, and investors are advised to compare Kopran against peers with stronger technical and fundamental profiles.
Summary of Key Technical Metrics:
- Current Price: ₹137.95 (down 3.23% on 21 Jan 2026)
- 52-Week Range: ₹123.75 – ₹216.25
- Moving Averages (Daily): Bearish
- MACD: Weekly Mildly Bullish, Monthly Bearish
- RSI: Neutral (Weekly & Monthly)
- Bollinger Bands: Bearish (Weekly & Monthly)
- KST: Bearish (Weekly & Monthly)
- OBV: Bullish (Weekly & Monthly)
- Dow Theory: Mildly Bearish (Weekly), No Trend (Monthly)
- Mojo Score: 26.0 (Strong Sell, downgraded from Sell on 20 Jan 2026)
Investors should continue to monitor these technical parameters closely, alongside fundamental developments, to gauge the stock’s trajectory in the coming weeks.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
